Domenico D’Amico

Domenico D’Amico


Research Focus & Metrics

Academic Career Length

39Years (1988-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 January 2012 in Cephalalgia
Verified
Journal Article
Closed access
PDF file
PTPeer Tfelt-Hansen
Peer Tfelt-Hansen
JPJulio Pascual
Julio Pascual
NRNabih Ramadan
Nabih Ramadan
CDCarl Dahlöf
Carl Dahlöf
DDDomenico D’Amico
Domenico D’Amico
TSTodd Schwedt
Todd Schwedt

1 November 1996 in Cephalalgia
Verified
Journal Article
Closed access
Massimo LeoneMassimo Leone
Massimo Leone
DDDomenico D’Amico
Domenico D’Amico
FMF Moschiano
F Moschiano
FFF Fraschini
F Fraschini
GBG Bussone
G Bussone

28 March 2000 in Neurology
Verified
Journal Article
Closed access
PDF file
Massimo LeoneMassimo Leone
Massimo Leone
DDDomenico D’Amico
Domenico D’Amico
FFF. Frediani
F. Frediani
FMF. Moschiano
F. Moschiano
LGLicia Grazzi
Licia Grazzi
GBG. Bussone
G. Bussone
Article abstract The authors performed a double-blind, double-dummy study to compare the efficacy of verapamil with placebo in the prophylaxis of episodic cluster headache. After 5 days’ run-in, 15 patients received verapamil (120 mg tid) and 15 received placebo (tid) for 14 days. The authors found a significant reduction in attack frequency and abortive agents consumption in the verapamil group. Side effects were mild. These findings provide objective evidence for the effectiveness of verapamil in episodic cluster headache prophylaxis.

1 June 2002 in Headache: The Journal of Head and Face Pain
Verified
Journal Article
Closed access
PDF file
LGLicia Grazzi
Licia Grazzi
FAFrank Andrasik
Frank Andrasik
DDDomenico D’Amico
Domenico D’Amico
Massimo LeoneMassimo Leone
Massimo Leone
SUSusanna Usai
Susanna Usai
GBGennaro Bussone
Gennaro Bussone

1 December 2001 in Cephalalgia
Verified
Journal Article
Closed access
DDDomenico D’Amico
Domenico D’Amico
PMP Mosconi
P Mosconi
SGS Genco
S Genco
SUS Usai
S Usai
APAmp Prudenzano
Amp Prudenzano
GBG Bussone
G Bussone

23 September 2012 in The Journal of Headache and Pain
Verified
Journal Article
Open access
PDF file
ARAlberto Raggi
Alberto Raggi
AGAmbra Mara Giovannetti
Ambra Mara Giovannetti
RQRui Quintas
Rui Quintas
DDDomenico D’Amico
Domenico D’Amico
ACAlarcos Cieza
Alarcos Cieza
MLMatilde Leonardi
Matilde Leonardi
Migraine is a common disease which causes significant burden to individuals, in terms of personal suffering and activity reduction, and to societies, in terms of disease cost. The purpose of this study is to identify the most relevant psychosocial difficulties related to migraine, the variables associated with them and the most relevant determinants of their evolution over time. MEDLINE and PsychINFO were searched for studies published in English between 2000 and 2010 that examined psychosocial difficulties in persons with migraine with and without aura, from clinical trials and observational studies. Information on the description of each difficulty, its determinants of onset and change over time and associated variables were extracted and categorized at a higher level. In total, 34 difficulties have been collected from 51 papers: the most frequent were reduced vitality and fatigue, emotional problems, pain, difficulties at work, general physical and mental health, social functioning and global disability. Evidence exists that pharmacological treatments have an impact toward improvement in patients’ difficulties, in particular emotional problems, physical and mental health, difficulties with employment and global disability. Migraine treatments and decreased headaches frequency are the major determinants of improvements in psychosocial difficulties, while no information is available for determinants of worsening; understanding the role of such factors is of primary public health relevance, given the high prevalence and the relevant personal and societal costs of migraine.